Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet

Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet

Détails bibliographiques
Auteurs principaux:	Payel Kundu, Ines L. Paraiso, Jaewoo Choi, Cristobal L. Miranda, Chrissa Kioussi, Claudia S. Maier, Gerd Bobe, Jan F. Stevens, Jacob Raber
Format:	Article
Langue:	English
Publié:	The Company of Biologists 2022-11-01
Collection:	Disease Models & Mechanisms
Sujets:	western diet hippocampus water maze ceramides diacylglycerols farnesoid x receptor
Accès en ligne:	http://dmm.biologists.org/content/15/11/dmm049820

Documents similaires

Theabrownin alleviates nonalcoholic fatty liver disease by inhibiting the intestinal farnesoid X receptor–ceramide axis
par: Jieyi Wang, et autres
Publié: (2024-07-01)

ApoE isoform-dependent effects of xanthohumol on high fat diet-induced cognitive impairments and hippocampal metabolic pathways
par: Payel Kundu, et autres
Publié: (2022-10-01)

Changes in Plasma Bioactive Lipids and Inflammatory Markers during a Half-Marathon in Trained Athletes
par: Melania Gaggini, et autres
Publié: (2021-05-01)

A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice
par: Stephanie Mourad, et autres
Publié: (2024-03-01)

Human Brain Lipidomics: Investigation of Formalin Fixed Brains
par: Aaron W. Beger, et autres
Publié: (2022-06-01)

Effects of Fish Oil and Grape Seed Extract Combination on Hepatic Endogenous Antioxidants and Bioactive Lipids in Diet-Induced Early Stages of Insulin Resistance in Rats
par: Núria Taltavull, et autres
Publié: (2020-06-01)

Two Different Phospholipases C, Isc1 and Pgc1, Cooperate To Regulate Mitochondrial Function
par: Maria Balazova, et autres
Publié: (2022-12-01)

Onset of Senescence and Steatosis in Hepatocytes as a Consequence of a Shift in the Diacylglycerol/Ceramide Balance at the Plasma Membrane
par: Gergana Deevska, et autres
Publié: (2021-05-01)

Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation
par: Hongshan Li, et autres
Publié: (2022-08-01)

Stimulation of the farnesoid X receptor promotes M2 macrophage polarization
par: Thiranut Jaroonwitchawan, et autres
Publié: (2023-01-01)

Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota
par: Annika Wahlström, et autres
Publié: (2017-02-01)

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
par: Hideki Mori, et autres
Publié: (2022-07-01)

Effect of a Farnesoid X-receptor Agonist on Postprandial Lipemia in Rats Fed a Supraphysiological Fat Dozes
par: Yu. N. Alekhin, et autres
Publié: (2023-05-01)

Imaging the early stages of phospholipase C/sphingomyelinase activity on vesicles containing coexisting ordered-disordered and gel-fluid domains[S]
par: Maitane Ibarguren, et autres
Publié: (2011-04-01)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
par: Apollinariya V. Bogolyubova, et autres
Publié: (2017-12-01)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
par: Jianglian She, et autres
Publié: (2022-01-01)

Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis
par: Joana Torres, et autres
Publié: (2017-10-01)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
par: Sharon Manley, et autres
Publié: (2015-03-01)

Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes
par: Ewa Harasim-Symbor, et autres
Publié: (2020-04-01)

Phospholipases and Membrane Curvature: What Is Happening at the Surface?
par: María Laura Fanani, et autres
Publié: (2023-02-01)

Punicalagin alleviates hypercholesterolemia in mice through modulating farnesoid X receptor signaling and modulating gut microbiota
par: Huanhuan Liu, et autres
Publié: (2025-01-01)

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment
par: Jiangtao Fu, et autres
Publié: (2024-05-01)

Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway
par: Yang Fan, et autres
Publié: (2023-11-01)

PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis
par: Michael Trauner, et autres
Publié: (2023-03-01)

Saffron offers hepatoprotection via up-regulation of hepatic farnesoid-X-activated receptors in a rat model of acetaminophen-induced hepatotoxicity
par: Vahid Jamshidi, et autres
Publié: (2021-11-01)

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension
par: John D. Imig
Publié: (2023-06-01)

Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages
par: Shan Cao, et autres
Publié: (2021-04-01)

Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice
par: Yuxiang Qiu, et autres
Publié: (2023-09-01)

Proteomics and lipidomic analysis reveal dysregulated pathways associated with loss of sacsin
par: Daniele Galatolo, et autres
Publié: (2024-06-01)

Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA
par: Longying Jiang, et autres
Publié: (2023-01-01)

Alpha-linolenic acid inhibits hepatocellular carcinoma cell growth through Farnesoid X receptor/β-catenin signaling pathway
par: Shu Feng, et autres
Publié: (2022-08-01)

Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells
par: Bin Wu, et autres
Publié: (2019-11-01)

Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity
par: Sharon Manley, et autres
Publié: (2014-01-01)

Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver
par: Lai Peng, et autres
Publié: (2016-09-01)

Computational study of novel natural agonists targeting farnesoid X receptor
par: Xindan Hu, et autres
Publié: (2024-07-01)

Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation
par: Peijie Wu, et autres
Publié: (2021-12-01)

Mangrove Tirucallane- and Apotirucallane-Type Triterpenoids: Structure Diversity of the C-17 Side-Chain and Natural Agonists of Human Farnesoid/Pregnane–X–Receptor
par: Zhong-Ping Jiang, et autres
Publié: (2018-12-01)

The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity
par: Kemp M. Anderson, et autres
Publié: (2021-11-01)

TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells
par: Berggren-Söderlund Maria, et autres
Publié: (2011-11-01)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
par: Mengjiao Zhou, et autres
Publié: (2022-10-01)